Gankyrin modulated non-small cell lung cancer progression via glycolysis metabolism in a YAP1-dependent manner

[1]  D. Cheng,et al.  YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression , 2021, Cell Death & Disease.

[2]  S. Batra,et al.  RNA-based therapies: A cog in the wheel of lung cancer defense , 2021, Molecular Cancer.

[3]  P. Zhu,et al.  Di-methylation of CD147-K234 Promotes the Progression of NSCLC by Enhancing Lactate Export. , 2021, Cell metabolism.

[4]  K. Guan,et al.  Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine , 2020, Nature Reviews Drug Discovery.

[5]  X. Cui,et al.  Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma , 2020, Cell Death & Disease.

[6]  I. Soto-Cruz,et al.  Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes , 2020, Cancers.

[7]  F. Cai,et al.  Epigenetic regulation of the Warburg effect by H2B monoubiquitination , 2019, Cell Death & Differentiation.

[8]  Shannon M. White,et al.  A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas. , 2019, Developmental cell.

[9]  Wei Wei,et al.  Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnostics , 2019, Nature Communications.

[10]  K. Guan,et al.  The Hippo Pathway: Biology and Pathophysiology. , 2019, Annual review of biochemistry.

[11]  Ying-jian Liang,et al.  Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma. , 2019, Cancer letters.

[12]  R. An,et al.  Gankyrin promotes osteosarcoma tumorigenesis by forming a positive feedback loop with YAP. , 2019, Cellular signalling.

[13]  Ja Hyun Koo,et al.  Interplay between YAP/TAZ and Metabolism. , 2018, Cell metabolism.

[14]  R. De Maria,et al.  The Hippo pathway in normal development and cancer , 2018, Pharmacology & therapeutics.

[15]  H. Shan,et al.  YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD , 2018, Cell Death & Disease.

[16]  Robert A. Weinberg,et al.  EMT in cancer , 2018, Nature Reviews Cancer.

[17]  Hongbing Zhang,et al.  Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis , 2018, Cell Death & Differentiation.

[18]  Marc W Kirschner,et al.  Conformational Landscape of the p28-Bound Human Proteasome Regulatory Particle. , 2017, Molecular cell.

[19]  Z. Xuan,et al.  The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition , 2017, Nature Communications.

[20]  Ying Sun,et al.  Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway , 2016, Oncotarget.

[21]  John M. Asara,et al.  Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth , 2016, Nature Cell Biology.

[22]  Tao Luo,et al.  PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression , 2016, Autophagy.

[23]  Stefano Piccolo,et al.  YAP/TAZ at the Roots of Cancer. , 2016, Cancer cell.

[24]  R. Bast,et al.  Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway , 2016, Oncogene.

[25]  Hong-Yang Wang,et al.  Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma , 2016, The Journal of experimental medicine.

[26]  S. Dupont,et al.  Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways. , 2016, Trends in cell biology.

[27]  W. Fang,et al.  Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway , 2015, Journal of Hematology & Oncology.

[28]  G. Halder,et al.  The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment , 2013, Nature Reviews Drug Discovery.

[29]  W. Harris,et al.  Metabolism in physiological cell proliferation and differentiation. , 2013, Trends in cell biology.

[30]  Chi V. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[31]  Jing Fu,et al.  Oncoprotein p28GANK binds to RelA and retains NF-κB in the cytoplasm through nuclear export , 2007, Cell Research.

[32]  T. Sakurai,et al.  The oncoprotein gankyrin interacts with RelA and suppresses NF-κB activity , 2007 .

[33]  Katsuhiko Itoh,et al.  Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas , 2000, Nature Medicine.

[34]  T. Klaenhammer,et al.  Application of electroporation for transfer of plasmid DNA to Lactobacillus, Lactococcus, Leuconostoc, Listeria, Pediococcus, Bacillus, Staphylococcus, Enterococcus and Propionibacterium , 1988, Molecular microbiology.